Atlas Trials

Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy

Clinical trial NCT04443244 · COMPLETED

Trial details

NCT number
NCT04443244
Sponsor
Hugel
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Benign Masseteric Hypertrophy
Start date
2020-05-27
Primary completion
2020-11-18
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.